Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Achieving Faster, Simpler Validation Through Crowdsource UAT
An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
-
Harnessing The Power Of eCOA Technology
Get an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.
-
NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO
Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.
-
Data Visualization For Clinical Operations: Transforming Insights Into Action
Data visualization transforms complex clinical trial data into actionable insights, significantly aiding in decision-making and trial management.
-
Realizing The Potential Of AI And Machine Learning In Clinical Research
The life sciences industry has not yet scaled or realized the full potential of AI/ML. Here are four real-world use cases that can encourage researchers to unlock new efficiencies and insights in their studies.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
The New Standard In Participant-Centric Trials
Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
-
Breaking Free From Process Paralysis In Clinical Trials
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
The Hidden Cost Of Preferred Vendors
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
-
Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC
Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.